MOS
NKTR icon

MGO One Seven’s Nektar Therapeutics NKTR Stock Holding History

MGO One Seven’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$118K Buy
+74
New +$95.3K 0.05% 391

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MGO One Seven's NKTR Position: Q1 2018 in Review

MGO One Seven opened a new position in Nektar Therapeutics (NKTR) in Q1 2018: 74 shares worth $118K. The stake represents 0.05% of the portfolio and ranks #391 among its holdings.

358 funds tracked by Wall St. Rank hold NKTR as of Q1 2018.

  • MGO One Seven held 74 shares of Nektar Therapeutics worth $118K as of Q1 2018.
  • Nektar Therapeutics was a new MGO One Seven position in Q1 2018.
  • Nektar Therapeutics made up 0.05% of MGO One Seven's portfolio in Q1 2018, its #391 holding.
  • 358 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2018.

Based on MGO One Seven's 13F filing for Q1 2018, filed 15 May 2018.